Workers at the plant accidentally conflated the ingredients of Johnson & Johnson’s COVID-19 vaccine several weeks ago, ruining about 15 million doses. The mistake, which federal officials said was a human error, forced regulators to delay authorization of the plant’s production lines, according to the Times.
Emergent BioSolutions has contracted with both Johnson & Johnson and AstraZeneca to help produce their COVID-19 vaccines.
The error doesn’t affect the Johnson & Johnson vaccines now being distributed throughout the U.S., the Times reported. Those doses were made in the Netherlands.
But all future shipments of the Johnson & Johnson vaccine were supposed to come from the Emergent plant in Baltimore.
Federal officials told the Times they still expect to have enough doses of COVID-19 vaccines to fulfill President Joe Biden’s promise to vaccinate every adult by the end of May.
Read the full article here.
More articles on pharmacy:
California sheriff’s office ignored warning, implied man’s death was linked to COVID-19 vaccine
Pfizer, BioNTech to test version of their COVID-19 vaccine that doesn’t need ultracold storage
8 key first-time generic drugs the FDA approved in 2020
